If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.65    0.025 (1.54%)
Bid:
1.35
Ask:
2.30
Spread: 0.95 (70.37%)
Market Cap: £5.79m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

23 Dec 2009 15:55

RNS Number : 6704E
Proteome Sciences PLC
23 December 2009
 



Proteome Sciences plc 

("Proteome Sciences" or "the Company")

Resignation of Director 

and 

Appointment of Chief Operating Officer

23rd December 2009: The Board of Proteome Sciences announces that Dr. Peter Schulz-Knappe will be leaving Proteome Sciences R&D GmbH & Co. KG on 31st December 2009 in order to be based more closely to his family, at which point he will resign as a director from the Company. The directors would like to thank Dr. Schulz-Knappe for his considerable contribution to the Company's progress and wish him every success in the future.

The Company is pleased to announce that Dr. Ian Pike has been appointed Chief Operating Officer of the Company and its subsidiaries and that Dr. Hans-Dieter Zucht has been appointed as Chief Technical Officer of Proteome Sciences R&D GmbH Co. KG in Frankfurt. Neither of these are appointments to the board of Proteome Sciences.

Ends

For further information please contact: 

Proteome Sciences plc

www.proteomics.com

Tel: +44 (0)1932 865065

Christopher Pearce, Chief Executive

James Malthouse, Finance Director 

Dr. Ian Pike, Chief Operating Officer

Email: christopher.pearce@proteomics.com

Email: james.malthouse@proteomics.com

Email: ian.pike@proteomics.com

Public Relations

IKON Associates 

Adrian Shaw

Tel: +44 (0)1483 271291

Mobile: +44 (0)797 9900733

Email: adrian@ikonassociates.com

Redleaf Communications Ltd. 

Samantha Robbins / Anna Dunkin 

Tel: +44 (0)20 7566 6700

Email: proteome@redleafpr.com

Nominated Adviser

Noble & Company Ltd.

John Llewellyn-Lloyd

Tel: +44 (0)20 7763 2200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEXLFLKLBEFBZ
Date   Source Headline
14th Aug 201810:03 amRNSDirector/PDMR Shareholding
9th Aug 20181:23 pmRNSDirector/PDMR Shareholding
2nd Aug 201810:03 amRNSDirector/PDMR Shareholding
31st Jul 20184:09 pmRNSDirector/PDMR Shareholding
27th Jul 201812:21 pmRNSDirector/PDMR Shareholding
24th Jul 20187:00 amRNSInterim Results
4th Jul 20184:40 pmRNSSecond Price Monitoring Extn
4th Jul 20184:35 pmRNSPrice Monitoring Extension
3rd Jul 20187:00 amRNSLoan Agreement and Notice of Results
18th Jun 20184:40 pmRNSSecond Price Monitoring Extn
18th Jun 20184:35 pmRNSPrice Monitoring Extension
30th May 20181:36 pmRNSAGM Statement
24th Apr 20187:00 amRNSBoard Appointment
24th Apr 20187:00 amRNSPreliminary Results
3rd Apr 201810:40 amRNSBlock Admission return
3rd Apr 20187:00 amRNSLicense Agreement Extension
28th Mar 20187:00 amRNSNotice of Results
22nd Mar 20181:18 pmRNSDirector/PDMR Shareholding
15th Mar 20184:40 pmRNSSecond Price Monitoring Extn
15th Mar 20184:35 pmRNSPrice Monitoring Extension
12th Feb 20187:00 amRNSTrading Update
10th Nov 201710:11 amRNSHolding(s) in Company
8th Nov 201712:00 pmRNSDirector/PDMR Shareholding
27th Oct 201711:30 amRNSHolding(s) in Company
27th Oct 201711:30 amRNSDirector/PDMR Shareholding
23rd Oct 201712:00 pmRNSDirector/PDMR Shareholding
23rd Oct 201712:00 pmRNSHolding(s) in Company
20th Oct 201712:58 pmRNSHolding(s) in Company
18th Oct 20177:00 amRNSGCLP Accreditation and Trading Update
3rd Oct 20172:25 pmRNSBlock Admission Return
1st Sep 201712:08 pmRNSIssue of Equity
1st Aug 20177:00 amRNSDirectorate Changes
25th Jul 20177:00 amRNSInterim results for the 6 months to 30 June 2017
11th Jul 201712:00 pmRNSNotice of Results
30th Jun 201710:31 amRNSHolding(s) in Company
30th Jun 20177:00 amRNSStroke Diagnostic- Research Milestone Achieved
12th Jun 20177:00 amRNSNew Registered Address
8th Jun 20174:40 pmRNSSecond Price Monitoring Extn
8th Jun 20174:35 pmRNSPrice Monitoring Extension
15th May 20177:00 amRNSDirector/PDMR Shareholding
10th May 201710:09 amRNSDirector/PDMR Shareholding
5th May 201712:30 pmRNSDirector/PDMR Shareholding
4th May 20172:23 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSDirector/PDMR Shareholding
28th Apr 20174:58 pmRNSDirector/PDMR Shareholding
28th Apr 20174:54 pmRNSHolding(s) in Company
25th Apr 20171:34 pmRNSAGM Statement and Result of AGM
11th Apr 20177:00 amRNSDirector Dealing and Total Voting Rights
4th Apr 20175:00 pmRNSHolding(s) in Company
4th Apr 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.